{"id":"NCT00596466","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","briefTitle":"Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures","officialTitle":"An Open-Label Multicenter Extension Study To Determine Long Term Safety And Efficacy Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-04","primaryCompletion":"2011-12","completion":"2011-12","firstPosted":"2008-01-17","resultsPosted":"2012-09-11","lastUpdate":"2021-01-26"},"enrollment":75,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Epilepsy"],"interventions":[{"type":"DRUG","name":"pregabalin","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"}],"summary":"This study will evaluate the long term safety and efficacy of pregabalin (Lyrica) when administered by itself (without any other anti-epileptic medication) to epilepsy patients for the treatment of partial seizures. This is an extension study to a previous clinical trial.","primaryOutcome":{"measure":"Seizure Frequency","timeFrame":"Baseline up to Week 28","effectByArm":[],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":1},"locations":{"siteCount":44,"countries":["United States","Czechia","Hong Kong","Ukraine"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":73},"commonTop":["Nausea","Headache","Weight increased","Arthralgia","Convulsion"]}}